Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by Evangelos Giamarellos-Bourboulis and Miltiades Kyprianou.
Evangelos Giamarellos-Bourboulis
Connection Strength
0.825
Miltiades Kyprianou
  1. Early treatment of COVID-19 with anakinra guided by soluble urokinase plasminogen receptor plasma levels: a double-blind, randomized controlled phase 3 trial. Nat Med. 2021 10; 27(10):1752-1760.
    View in: PubMed
    Score: 0.241
  2. An open label trial of anakinra to prevent respiratory failure in COVID-19. Elife. 2021 03 08; 10.
    View in: PubMed
    Score: 0.233
  3. A novel optical biosensor for the early diagnosis of sepsis and severe Covid-19: the PROUD study. BMC Infect Dis. 2020 Nov 19; 20(1):860.
    View in: PubMed
    Score: 0.229
  4. Coronavirus Disease 2019 as Cause of Viral Sepsis: A Systematic Review and Meta-Analysis. Crit Care Med. 2021 12 01; 49(12):2042-2057.
    View in: PubMed
    Score: 0.061
  5. Effect of anakinra on mortality in patients with COVID-19: a systematic review and patient-level meta-analysis. Lancet Rheumatol. 2021 Oct; 3(10):e690-e697.
    View in: PubMed
    Score: 0.060
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.